Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep;43(9):920-931.
doi: 10.1007/s12272-020-01270-x. Epub 2020 Sep 25.

White matter and neurological disorders

Affiliations
Review

White matter and neurological disorders

Han-Gyu Bae et al. Arch Pharm Res. 2020 Sep.

Erratum in

Abstract

The central nervous system is simply divided into two distinct anatomical regions based on the color of tissues, i.e. the gray and white matter. The gray matter is composed of neuronal cell bodies, glial cells, dendrites, immune cells, and the vascular system, while the white matter is composed of concentrated myelinated axonal fibers extending from neuronal soma and glial cells, such as oligodendrocyte precursor cells (OPCs), oligodendrocytes, astrocytes, and microglia. As neuronal cell bodies are located in the gray matter, great attention has been focused mainly on the gray matter regarding the understanding of the functions of the brain throughout the neurophysiological areas, leading to a scenario in which the function of the white matter is relatively underestimated or has not received much attention. However, increasing evidence shows that the white matter plays highly significant and pivotal functions in the brain based on the fact that its abnormalities are associated with numerous neurological diseases. In this review, we will broadly discuss the pathways and functions of myelination, which is one of the main processes that modulate the functions of the white matter, as well as the manner in which its abnormalities are related to neurological disorders.

Keywords: Alzheimer’s disease; Huntington’s disease; Multiple sclerosis; Myelination; Neurological disorders; White matter.

PubMed Disclaimer

References

    1. Arai K, Lo EH (2017) Chap. 18 - Gliogenesis. In: Caplan LR, Biller J, Leary MC, Lo EH, Thomas AJ, Yenari M, Zhang JH (eds) Primer on cerebrovascular diseases, 2nd edn. Academic Press, San Diego, pp 91–95. https://doi.org/10.1016/B978-0-12-803058-5.00018-7 - DOI
    1. Arancibia-Cárcamo IL, Ford MC, Cossell L, Ishida K, Tohyama K, Attwell D (2017) Node of Ranvier length as a potential regulator of myelinated axon conduction speed. eLife 6:e23329. https://doi.org/10.7554/eLife.23329 - DOI - PubMed - PMC
    1. Bahn G, Jo D-G (2019) Therapeutic approaches to Alzheimer’s disease through modulation of NRF2. Neuromolecular Med 21:1–11. https://doi.org/10.1007/s12017-018-08523-5 - DOI - PubMed
    1. Bahn G, Park J-S, Yun UJ et al (2019) NRF2/ARE pathway negatively regulates BACE1 expression and ameliorates cognitive deficits in mouse Alzheimer’s models. Proc Natl Acad Sci USA 116:12516–12523. https://doi.org/10.1073/pnas.1819541116 - DOI - PubMed
    1. Bar E, Barak B (2019) Microglia roles in synaptic plasticity and myelination in homeostatic conditions and neurodevelopmental disorders. Glia 67:2125–2141. https://doi.org/10.1002/glia.23637 - DOI - PubMed

MeSH terms

LinkOut - more resources